Risk stratification and long-term monitoring in pediatric thyroid cancer: predictive markers for disease persistence
European Thyroid Journal · 01.04.2026 · 15 (2)
DOI: 10.1530/etj-25-0236 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Thyroid Journal, online erschienen am 13.03.2026. Verfasst von Mariana Mazeu Barbosa de Oliveira und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade de Ciências Médicas da Santa Casa de São Paulo Ringgold Standard Institution - Endocrinology, São Paulo, Brazil. Hauptthemen laut MEDLINE: Thyroid Neoplasms. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Initial risk stratification and dynamic risk stratification are crucial in managing pediatric differentiated thyroid carcinoma (DTC), aiming to guide treatment and long-term follow-up. While adult dynamic stratification is well established, pediatric data remain limited, and no formal recommendations exist for its use.
Objective
To evaluate the prognostic value of early dynamic risk stratification (EDRS) and postoperative stimulated thyroglobulin (sPOTg) in predicting long-term outcomes in pediatric DTC and to compare EDRS with initial ATA pediatric risk stratification (IRS).
Methods
We conducted a retrospective cohort study of 123 patients ≤18 years with DTC treated at a tertiary center. IRS and EDRS (1–3 years post-treatment) were compared to late dynamic response (LDRS, ≥10 years post-treatment). A total of 83 patients had complete long-term follow-up data. Associations were assessed using chi-square tests, logistic regression, Cohen’s kappa, and Cramér’s V. ROC curve analysis evaluated the predictive value of sPOTg.
Results
Among 83 patients with ≥10 years of follow-up, EDRS showed a strong association with LDRS (Cramér’s V = 0.829; P < 0.001), outperforming IRS (Cramér’s V = 0.33; P = 0.0029). Concordance between EDRS and LDRS was substantial (kappa = 0.79). Stimulated postoperative thyroglobulin (sPOTg) showed good discriminatory performance for disease persistence, with AUCs of 0.84 (95% CI: 0.70–0.95) at 1–3 years and 0.81 at ≥10 years.
Conclusion
Early dynamic response is a strong predictor of long-term outcomes and may surpass IRS in prognostic accuracy. sPOTg is a valuable biomarker for both early and late risk assessment. Prospective multicenter validation is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculdade de Ciências Médicas da Santa Casa de São Paulo Ringgold Standard Institution - Endocrinology, São Paulo, Brazil.
- UNICAMP Ringgold Standard Institution - Endocrinology, Campinas, SP, Brazil.
- Faculdade de Ciências Médicas da Santa Casa de São Paulo Ringgold Standard Institution - Pediatric Endocrinology, São Paulo, SP, Brazil.
ORCID-Profile: Mariana Mazeu Barbosa de Oliveira, Marilia Martins Silveira Marone, Cristiane Kochi, Carolina Ferraz, Rosália Padovani
Zitieren
APA
de Oliveira, M. M. B., Ward, L. S., Cury, A. N., Scalissi, N. M., Silveira Marone, M. M., Longui, C. A., Kochi, C., Monte, O., Ferraz, C., & Padovani, R. (2026). Risk stratification and long-term monitoring in pediatric thyroid cancer: predictive markers for disease persistence. European Thyroid Journal, 15(2). https://doi.org/10.1530/etj-25-0236
Vancouver
de Oliveira MMB, Ward LS, Cury AN, Scalissi NM, Silveira Marone MM, Longui CA, et al. Risk stratification and long-term monitoring in pediatric thyroid cancer: predictive markers for disease persistence. European Thyroid Journal. 2026;15(2). doi:10.1530/etj-25-0236
BibTeX
@article{deOliveira2026,
author = {de Oliveira, Mariana Mazeu Barbosa and Ward, Laura Sterian and Cury, Adriano Namo and Scalissi, Nilza Maria and Silveira Marone, Marilia Martins and Longui, Carlos Alberto and Kochi, Cristiane and Monte, Osmar and Ferraz, Carolina and Padovani, Rosália},
title = {Risk stratification and long-term monitoring in pediatric thyroid cancer: predictive markers for disease persistence},
journal = {European Thyroid Journal},
year = {2026},
volume = {15},
number = {2},
doi = {10.1530/etj-25-0236}
}
EUVIMED